Fermenta Biotech quarterly results and financials

Fermenta Biotech (FERMENTA)₹430.45−5.40%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Fermenta Biotech reported sales of ₹122 Cr, down 10.7% from Jun 2025, and net profit of ₹9.57 Cr, down 55.8% year on year. For the year to Mar 2026, sales were ₹524 Cr and net profit ₹70.28 Cr.

Sales (Jun 2026): ₹122 Cr
Net profit (Jun 2026): ₹9.57 Cr
Sales (FY Mar 2026): ₹524 Cr
Net profit (FY Mar 2026): ₹70.28 Cr
EPS (Jun 2026): ₹3.32
Borrowings (Mar 2026): ₹113 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Fermenta Biotech quarterly results

₹ crore unless stated; each column is a quarter.

Fermenta Biotech Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	56.95	99.07	97.47	78.20	95.05	156	140	136	130	138	122	122
Expenses	70.69	73.64	91.80	77.16	76.08	103	103	108	103	112	101	104
Operating Profit	−13.95	25.18	5.39	0.81	18.82	53.38	37.05	28.33	26.71	25.04	20.06	18.11
OPM %	−24.5%	25.3%	5.5%	1.0%	19.7%	34.0%	26.4%	20.7%	20.4%	18.1%	16.4%	14.8%
Other Income	−5.51	2.51	5.37	2.81	2.87	2.22	3.88	8.75	5.42	0.91	14.10	4.36
Interest	3.68	5.18	3.38	3.42	3.68	4.07	2.98	3.10	2.57	3.02	2.81	2.53
Depreciation	5.90	6.36	6.44	6.10	6.12	6.06	5.84	5.78	5.39	5.35	5.09	5.18
Profit before tax	−28.99	16.03	0.90	−5.91	11.79	45.21	31.92	28.03	24.01	17.43	26.15	14.65
Tax %	0.0%	37.8%	884.6%	0.0%	5.9%	16.4%	−4.2%	23.1%	25.2%	31.2%	29.0%	35.2%
Exceptional items	−7.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−2.01	6.02	0.00
Net Profit	−29.17	10.03	−7.16	−5.96	11.16	38.02	33.46	21.67	18.10	12.07	18.68	9.57
EPS (Rs)	−9.69	3.34	−2.35	−1.99	3.86	12.55	11.69	7.43	6.15	4.32	6.51	3.32

Fermenta Biotech profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Fermenta Biotech Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	155	164	302	403	292	376	397	349	335	469	524	512
Expenses	134	152	209	248	225	293	335	330	306	351	421	421
Operating Profit	21.07	12.03	93.21	156	66.14	83.26	62.13	18.06	28.06	115	101	89.92
OPM %	13.0%	7.0%	31.0%	39.0%	23.0%	22.0%	16.0%	5.0%	8.0%	25.0%	19.0%	17.6%
Other Income	0.99	2.99	8.99	5.99	11.96	7.98	7.98	−19.94	3.99	6.98	28.92	24.79
Interest	5.99	9.99	13.99	20.97	19.98	18.99	17.98	20.99	16.99	14.99	12.99	10.93
Depreciation	7.97	9.96	11.94	11.95	14.94	19.93	25.89	27.91	24.91	23.91	21.92	21.01
Profit before tax	6.99	−5.98	75.79	129	42.91	51.87	26.92	−50.89	−9.97	82.81	95.77	82.24
Tax %	61.0%	49.0%	28.0%	8.0%	−37.0%	18.0%	44.0%	4.0%	143.0%	8.0%	27.0%	—
Exceptional items	0.00	0.00	1.01	−5.02	2.01	0.00	0.00	−27.07	−6.01	−4.01	9.03	4.01
Net Profit	2.01	−9.03	46.19	117	60.21	43.20	15.05	−53.16	−24.08	76.31	70.28	58.42
EPS (Rs)	−0.42	−4.13	12.22	42.68	20.24	15.45	5.24	−17.35	−7.83	26.13	24.38	20.30
Dividend payout %	−51.0%	−5.0%	2.0%	1.0%	24.0%	16.0%	23.0%	−7.0%	−16.0%	9.0%	15.0%	—

Fermenta Biotech balance sheet

₹ crore, at each year end.

Fermenta Biotech Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	1.99	1.99	1.99	1.99	4.98	13.96	13.96	13.96	13.96	13.97	14.97	13.95
Reserves	129	128	142	122	246	295	346	358	301	274	348	391
Borrowings	71.06	88.99	87.02	173	209	224	232	239	220	139	115	113
Other Liabilities	59.71	69.67	74.64	86.59	91.56	79.62	93.55	95.54	102	119	136	127
Total Liabilities	262	288	307	384	550	613	686	706	636	547	613	647
Fixed Assets	84.97	168	172	177	178	200	263	299	267	269	227	220
CWIP	65.22	6.02	5.02	4.02	22.07	71.23	57.24	35.12	45.14	2.01	16.05	13.04
Investments	17.94	14.94	17.93	9.96	7.97	0.00	0.00	0.00	2.99	0.00	0.00	0.00
Other Assets	93.73	98.61	112	192	343	341	366	372	320	276	371	413
Inventories	21.93	27.93	38.91	50.86	87.83	129	162	159	130	86.74	124	153
Trade receivables	35.90	42.90	44.88	68.85	65.83	69.84	67.86	86.75	41.92	69.84	94.67	112
Cash & equivalents	17.04	5.01	2.01	33.09	91.17	33.05	45.09	34.06	58.10	60.13	72.11	41.10
Total Assets	262	288	307	384	550	613	686	706	636	547	613	647

Fermenta Biotech cash flow

₹ crore, for each year.

Fermenta Biotech Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	14.95	3.98	1.99	58.79	89.73	33.89	62.75	42.81	115	105	40.82	92.71
Cash from investing activity	−18.02	−13.02	7.01	−101	−97.05	−44.04	−41.06	−26.04	−55.08	−16.01	0.00	−43.08
Cash from financing activity	1.01	10.01	−12.01	88.96	11.99	−47.03	−0.99	−21.99	−40.97	−91.06	−50.99	−42.01
Net cash flow	−1.99	0.99	−3.99	46.82	5.98	−56.81	20.93	−3.99	18.94	−0.99	−9.95	7.98
Capex	35.10	30.42	19.00	19.50	35.73	68.39	55.19	37.09	40.44	19.18	22.11	30.29
Free cash flow	−19.99	−24.97	−16.98	41.98	54.97	−33.95	6.99	5.99	75.94	85.90	37.93	62.97
CFO / OP %	119.0%	35.0%	34.9%	83.0%	79.0%	73.0%	91.9%	84.9%	610.0%	370.0%	38.0%	108.0%

Fermenta Biotech ratios

Working-capital days and returns, by year.

Fermenta Biotech Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	91	101	99	83	59	87	66	80	44	76	74	78
Inventory days	124	159	207	233	346	593	440	379	308	244	284	289
Days payable	94	112	146	182	168	259	168	153	108	181	177	146
Cash conversion cycle	123	149	161	135	238	422	339	307	245	140	182	222
Working capital days	−61	−49	33	54	43	70	54	67	−18	9	40	96
ROCE %	3.0%	6.0%	2.0%	31.1%	41.0%	12.0%	13.0%	7.0%	0.0%	3.0%	23.0%	21.0%

Fermenta Biotech: frequently asked questions

What are the latest quarterly results of Fermenta Biotech?

For the Jun 2026 quarter, Fermenta Biotech reported sales of ₹122 Cr, down 10.7% year on year and net profit of ₹9.57 Cr, down 55.8% year on year. The operating margin was 14.8%.

What is the annual revenue of Fermenta Biotech?

Fermenta Biotech's sales for the year to Mar 2026 were ₹524 Cr; over the last twelve months they were ₹512 Cr.

What is the net profit of Fermenta Biotech?

Net profit for the year to Mar 2026 was ₹70.28 Cr, and ₹58.42 Cr over the last twelve months. Earnings per share over the same trailing period were ₹20.30.

How much debt does Fermenta Biotech have?

Fermenta Biotech reported borrowings of ₹113 Cr at Mar 2026, against cash and equivalents of ₹41.10 Cr.

What is the free cash flow of Fermenta Biotech?

Cash from operations was ₹92.71 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹62.97 Cr.

Loading…